|
|
|
|
|
|
 |
| 20 January 2010 |
|
|
|
|
Edition :: 74 Vol
:: II |
|
|
|
|
Outsourcing |
Investment |
Economics |
Spotlight |
Upcoming Events |
Comments & opinions |
| A Publication of Consulate General of India, Johannesburg |
« Back |
|
|
|
| Economics |
|
| Print this page |
 Indian biotech industry to top USD 10 billion by 2015
|
| Source: The Hindu |
Place : Bangalore |
| News
Date : 19 January 2010 |
|
|
Bangalore: Positive triggers would propel India?s biotech sector to become a USD ten billion industry by 2015, CMD of Biocon Ltd., Kiran Mazumdar-Shaw, said on Tuesday.
The BT industry veteran expects the industry to grow to USD five billion by next year.
?By 2015, we expect it to become a size of USD ten billion?, Mazumdar-Shaw told reporters.
India?s BT industry is at an inflexion point, has attained ?critical mass? and created a platform that allows it to leapfrog and delivery exponential growth, she said.
?India is today becoming the vaccine capital of the world. Bio-manufacturing offers a huge potential and already there are indications that many global contract manufacturers announced they will be shifting their base from Europe to Asia. I think India will be one of the beneficiaries of that particular strategy?, Mazumdar-Shaw said.
Clinical trials, agri-biotech and bio-fuels are becoming big opportunities for India, she said. ?There are lot of growth drivers and trigger points which we think will deliver in the next five years?.
|
| |
| |
|
|
|